What is the starting dose of Mounjaro for weight loss?

Why does Mounjaro start at such a low dose if it is not the dose that causes weight loss?

This is a question our prescribers hear most weeks, and it is a fair one. At 2.5 mg the primary goal is settling your system. Tirzepatide works by activating both GIP and GLP-1 receptors, slowing how quickly the stomach empties and reducing appetite signals in the brain. That mechanism is powerful, and jumping straight to a higher dose significantly increases the chance of nausea, vomiting and digestive discomfort. The starter dose gives your gut four weeks to adapt before the first increase.

The full Mounjaro overview explains how the dual-receptor action differs from older GLP-1 medicines, but in plain terms: a slower start means fewer drop-outs and a better experience overall. Clinical trials (including the SURMOUNT-1 study, which the NHS tirzepatide information page references) used this same graduated schedule, starting participants at 2.5 mg before titrating upward.

If you tolerate the first four weeks well and your prescriber is satisfied, the dose moves to 5 mg. From there, increases continue in 2.5 mg steps (through 7.5, 10, 12.5 and up to 15 mg) each typically held for four weeks before the next review. The available UK strengths and what to expect at each step are covered on our guide to Mounjaro doses for weight loss.

Can I start Mounjaro at 5 mg to speed things up?

Some people arrive having read that a higher starting dose might get results faster, and it is understandable to want that. The short answer is that 5 mg is not the licensed starting dose in the UK for weight management, 2.5 mg is. A prescriber may have clinical reasons to begin at 5 mg in specific circumstances, but that is not routine, and no reputable UK prescriber would do it simply to accelerate progress.

If you have used tirzepatide before and are transferring to a new provider at a higher dose, a prescriber will ask for evidence of your current treatment before continuing at that level. That is standard clinical practice, not bureaucracy. The question of whether starting at 5 mg is ever appropriate has a longer answer worth reading if this applies to you.

Equally, staying on 2.5 mg beyond the initial four weeks is sometimes the right call, your prescriber may decide your body needs more time before moving up. That is not a setback. There is detailed information on what staying on 2.5 mg means for people in that position.

What side effects are most common at the starting dose?

Most people tolerate 2.5 mg better than any subsequent dose, precisely because it was designed with tolerability in mind. That said, some digestive effects are still possible from week one: nausea, loose stools, constipation, burping, or a general feeling of fullness that arrives earlier than you expect at meals. Fatigue and mild headaches occur in some people too. These tend to be at their most noticeable in the first two weeks and usually settle.

A small number of people experience more persistent symptoms. Dehydration matters, if vomiting or diarrhoea is severe, staying hydrated and contacting your prescriber promptly is important. The MHRA's Yellow Card scheme exists so that patients can report side effects directly, and doing so genuinely helps post-market safety monitoring for medicines like Mounjaro.

Pancreatitis is a less common but serious concern: severe stomach pain that spreads to the back, with or without vomiting, needs urgent medical attention rather than waiting it out. On balance, starting at the lowest dose is one of the reasons the tolerability profile of tirzepatide compares favourably in the trial data. Cost is a separate consideration, what Mounjaro costs privately in the UK is worth understanding alongside the clinical picture.

How does a prescriber decide when to increase the dose?

The prescriber looks at two things: how well you have tolerated the current dose, and whether you are making progress toward your weight goal. If side effects have been manageable and the four weeks are up, the standard next step is to move to 5 mg. If things have been rougher, holding at 2.5 mg for another month is entirely reasonable, the aim is to reach the highest dose you can tolerate, not the highest dose on the list.

Reaching the maintenance dose that actually produces meaningful weight loss takes months, not weeks. SURMOUNT-1 trial participants ran for 72 weeks, and the headline results (around 20 to 21% average body-weight reduction at 15 mg) reflected that full schedule. The practical guide to your first weeks on 2.5 mg covers what to track and when to get in touch with your prescriber.

At nume, every repeat order goes through a fresh clinical review before dispatch. That means a real prescriber checks your progress at each stage, not an automated renewal. If you have not yet spoken to anyone about whether tirzepatide is appropriate for you, starting a free consultation is the place to begin.